Allianz Asset Management GmbH Increases Stock Holdings in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Key Points

• Allianz Asset Management GmbH significantly increased its stake in Bioceres Crop Solutions by 77.5% during the first quarter, now owning 236,717 shares valued at approximately $1.08 million.
• Bioceres Crop Solutions reported a negative earnings per share of ($0.02), surpassing analysts' expectations of ($0.10), despite generating $59.60 million in revenue, which fell short of the $61.80 million forecast.
• Analysts have a consensus rating of "Moderate Buy" for Bioceres, with a revised price target set at $6.00 following Oppenheimer's recent downgrade.

Allianz Asset Management GmbH raised its holdings in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 77.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 236,717 shares of the company's stock after purchasing an additional 103,337 shares during the period. Allianz Asset Management GmbH owned approximately 0.38% of Bioceres Crop Solutions worth $1,081,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of BIOX. JPMorgan Chase & Co. grew its holdings in Bioceres Crop Solutions by 17.0% in the fourth quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock worth $640,000 after purchasing an additional 15,328 shares during the period. Jump Financial LLC purchased a new position in Bioceres Crop Solutions during the fourth quarter valued at approximately $72,000. Stifel Financial Corp grew its stake in Bioceres Crop Solutions by 51.9% during the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock valued at $377,000 after acquiring an additional 21,168 shares in the last quarter. Long Focus Capital Management LLC grew its stake in Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock worth $4,528,000 after buying an additional 421,931 shares in the last quarter. Finally, Northern Trust Corp purchased a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at $93,000. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Trading Up 0.6%

Shares of NASDAQ:BIOX traded up $0.02 on Monday, hitting $3.49. 22,505 shares of the company's stock were exchanged, compared to its average volume of 203,494. Bioceres Crop Solutions Corp. has a 12 month low of $3.30 and a 12 month high of $11.41. The stock has a market capitalization of $218.86 million, a price-to-earnings ratio of -24.93, a price-to-earnings-growth ratio of 1.48 and a beta of 0.44. The business's 50 day simple moving average is $4.39 and its two-hundred day simple moving average is $4.70. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.08. The firm had revenue of $59.60 million during the quarter, compared to the consensus estimate of $61.80 million. Bioceres Crop Solutions had a negative return on equity of 2.37% and a negative net margin of 2.14%. Analysts anticipate that Bioceres Crop Solutions Corp. will post -0.05 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have commented on BIOX. Wall Street Zen lowered shares of Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a report on Sunday. Oppenheimer cut their price objective on shares of Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 15th. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $8.38.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.